Thrivent Financial for Lutherans Sells 11,779 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Thrivent Financial for Lutherans lowered its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 4.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 239,695 shares of the company’s stock after selling 11,779 shares during the period. Thrivent Financial for Lutherans owned approximately 0.41% of Molina Healthcare worth $71,262,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of MOH. Wellington Management Group LLP grew its stake in Molina Healthcare by 12.8% in the 4th quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock valued at $1,384,215,000 after buying an additional 436,060 shares in the last quarter. Swedbank AB bought a new position in shares of Molina Healthcare in the first quarter worth $69,320,000. Jupiter Asset Management Ltd. grew its position in shares of Molina Healthcare by 434.6% in the second quarter. Jupiter Asset Management Ltd. now owns 185,606 shares of the company’s stock valued at $55,181,000 after purchasing an additional 150,890 shares in the last quarter. Capital Research Global Investors raised its stake in shares of Molina Healthcare by 5.4% during the 4th quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock valued at $878,086,000 after purchasing an additional 123,894 shares during the period. Finally, Renaissance Technologies LLC lifted its holdings in Molina Healthcare by 13.3% during the 2nd quarter. Renaissance Technologies LLC now owns 949,691 shares of the company’s stock worth $282,343,000 after purchasing an additional 111,154 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Molina Healthcare Price Performance

MOH opened at $351.42 on Friday. The stock has a market capitalization of $20.59 billion, a P/E ratio of 19.07, a PEG ratio of 1.20 and a beta of 0.57. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. Molina Healthcare, Inc. has a 12-month low of $282.96 and a 12-month high of $423.92. The stock has a 50-day moving average price of $335.60 and a 200-day moving average price of $343.15.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.73 by $0.13. The business had revenue of $9.88 billion during the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. Molina Healthcare’s revenue for the quarter was up 18.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.65 earnings per share. Equities analysts predict that Molina Healthcare, Inc. will post 23.5 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CAO Maurice Hebert sold 393 shares of the firm’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on MOH. Baird R W raised shares of Molina Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a research note on Tuesday, September 10th. StockNews.com lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday. Stephens reaffirmed an “equal weight” rating and issued a $320.00 price target on shares of Molina Healthcare in a report on Thursday, July 25th. Finally, Wells Fargo & Company boosted their target price on Molina Healthcare from $315.00 to $360.00 and gave the stock an “equal weight” rating in a research report on Monday, August 5th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Molina Healthcare has an average rating of “Hold” and a consensus price target of $378.00.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.